Madrigal Pharmaceuticals, Inc. MDGL FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s FX effect on cash?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported FX effect on cash of $1.32M in Q1 2026.
- What does FX effect on cash mean?
- The gain or loss in cash value caused by changes in foreign currency exchange rates.
- How do you interpret FX effect on cash?
- Fluctuations reflect macroeconomic currency trends rather than operational efficiency or management decisions.
- How does FX effect on cash compare across companies?
- Standard across all multinational corporations; magnitude depends on the geographic footprint of operations.